HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE SUBSTRATE-INDUCED CONFORMATIONAL-CHANGES AND THE MECHANISM OF INHIBITION BY NONNUCLEOSIDE INHIBITORS

被引:170
作者
RITTINGER, K [1 ]
DIVITA, G [1 ]
GOODY, RS [1 ]
机构
[1] MAX PLANCK INST MED RES,BIOPHYS ABT,D-69120 HEIDELBERG,GERMANY
关键词
D O I
10.1073/pnas.92.17.8046
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A combination of transient kinetic and equilibrium titration methods has been used to show that both primer/template and nucleotide binding to human immunedeficiency virus type 1 (HIV-1) reverse transcriptase are two-step processes. In both cases, after initial formation of relatively weakly bound states, isomerization reactions lead to tightly bound states, In the case of deoxynucleotide binding to the reverse transcriptase-primer/template complex, the second step in the interaction is rate-limiting in the overall reaction during processive polymerization. Discrimination against incorrect nucleotides occurs both in the initial weak binding and in the second step but is purely kinetic in the second step (as opposed to thermodynamic in the first step). Nonnucleoside inhibitors have a relatively small effect on nucleotide-binding steps (overall affinity is reduced by a factor of ca. 10), while the affinity of the primer/template duplex is increased by at least a factor of 10, The major effect of nonnucleoside inhibitors is on the chemical step (nucleotide transfer).
引用
收藏
页码:8046 / 8049
页数:4
相关论文
共 15 条
[1]   STRUCTURE OF HIV-1 REVERSE-TRANSCRIPTASE DNA COMPLEX AT 7-A RESOLUTION SHOWING ACTIVE-SITE LOCATIONS [J].
ARNOLD, E ;
JACOBOMOLINA, A ;
NANNI, RG ;
WILLIAMS, RL ;
LU, XD ;
DING, JP ;
CLARK, AD ;
ZHANG, AQ ;
FERRIS, AL ;
CLARK, P ;
HIZI, A ;
HUGHES, SH .
NATURE, 1992, 357 (6373) :85-89
[2]   AN ANTIVIRAL TARGET ON REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVEALED BY TETRAHYDROIMIDAZO[4,5,1-JK][1,4]BENZODIAZEPIN-2(1H)-ONE AND TETRAHYDROIMIDAZO-[4,5,1-JK][1,4]BENZODIAZEPIN-2(1H)-ONE-THIONE DERIVATIVES [J].
DEBYSER, Z ;
PAUWELS, R ;
ANDRIES, K ;
DESMYTER, J ;
KUKLA, M ;
JANSSEN, PAJ ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) :1451-1455
[3]   KINETICS OF INTERACTION OF HIV REVERSE-TRANSCRIPTASE WITH PRIMER TEMPLATE [J].
DIVITA, G ;
MULLER, B ;
IMMENDORFER, U ;
GAUTEL, M ;
RITTINGER, K ;
RESTLE, T ;
GOODY, RS .
BIOCHEMISTRY, 1993, 32 (31) :7966-7971
[4]   CRYSTAL-STRUCTURE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE COMPLEXED WITH DOUBLE-STRANDED DNA AT 3.0 ANGSTROM RESOLUTION SHOWS BENT DNA [J].
JACOBOMOLINA, A ;
DING, JP ;
NANNI, RG ;
CLARK, AD ;
LU, XD ;
TANTILLO, C ;
WILLIAMS, RL ;
KAMER, G ;
FERRIS, AL ;
CLARK, P ;
HIZI, A ;
HUGHES, SH ;
ARNOLD, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :6320-6324
[5]  
KATI WM, 1992, J BIOL CHEM, V267, P25988
[6]   CRYSTAL-STRUCTURE AT 3.5 ANGSTROM RESOLUTION OF HIV-1 REVERSE-TRANSCRIPTASE COMPLEXED WITH AN INHIBITOR [J].
KOHLSTAEDT, LA ;
WANG, J ;
FRIEDMAN, JM ;
RICE, PA ;
STEITZ, TA .
SCIENCE, 1992, 256 (5065) :1783-1790
[7]   INHIBITION OF HIV-1 REPLICATION BY A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR [J].
MERLUZZI, VJ ;
HARGRAVE, KD ;
LABADIA, M ;
GROZINGER, K ;
SKOOG, M ;
WU, JC ;
SHIH, CK ;
ECKNER, K ;
HATTOX, S ;
ADAMS, J ;
ROSEHTHAL, AS ;
FAANES, R ;
ECKNER, RJ ;
KOUP, RA ;
SULLIVAN, JL .
SCIENCE, 1990, 250 (4986) :1411-1413
[8]  
MULLER B, 1989, J BIOL CHEM, V264, P13975
[9]   INTERACTION OF FLUORESCENTLY LABELED DIDEOXYNUCLEOTIDES WITH HIV-1 REVERSE-TRANSCRIPTASE [J].
MULLER, B ;
RESTLE, T ;
REINSTEIN, J ;
GOODY, RS .
BIOCHEMISTRY, 1991, 30 (15) :3709-3715
[10]   INSIGHTS INTO DNA POLYMERIZATION MECHANISMS FROM STRUCTURE AND FUNCTION-ANALYSIS OF HIV-1 REVERSE-TRANSCRIPTASE [J].
PATEL, PH ;
JACOBOMOLINA, A ;
DING, JP ;
TANTILLO, C ;
CLARK, AD ;
RAAG, R ;
NANNI, RG ;
HUGHES, SH ;
ARNOLD, E .
BIOCHEMISTRY, 1995, 34 (16) :5351-5363